Quantification of glutaric and 3-hydroxyglutaric acids in urine of glutaric acidemia type I patients by HPLC with intramolecular excimer-forming fluorescence derivatization

被引:14
作者
Al-Dirbashi, OY
Jacob, M
Al-Amoudi, M
Al-Kahtani, K
Al-Odaib, A
El-Badaoui, F
Rashed, MS
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia
关键词
glutafic aciduria; 3-hydroxyglutaric acid; glutaric acid; excimer-forming fluorescence;
D O I
10.1016/j.cccn.2005.03.048
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
dBackground: Glutaric aciduria type I (GA1) is an autosomal recessive disorder that usually causes neurological damage. Early diagnosis of the disease prior to the appearance of clinical symptoms can lead to better outcomes. Methods: We describe a simple and selective HPLC method with intramolecular excimer-forming fluorescence derivatization to diagnose GAL Glutaric acid (GA) and 3-hydroxyglutaric acid (3HGA) in urine and an internal standard were derivatized with I-pyrenebutyric hydrazide (PBH). The derivatives were separated on a C-18 column and fluorometrically detected at 475 nm (excitation of 345 nm) with a run time of 18 min. Results: Excellent linearity over a wide range, reproducibility (coefficient of variation <= 14.5%), and sensitivity (limit of detection 0.4 mu mol/l 3HGA and 0.2 mu mol/l GA) were obtained. A retrospective study on previously diagnosed GA1 patients' urine from our laboratory archives between 1999 and 2004 was performed by analysts blinded to the study. Conclusions: The method enabled us to differentiate GA I cases (n =36) from controls (n =99), regardless of the years of urine storage. The method is valuable for both retrospective and prospective diagnoses of GA1. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 24 条
[1]  
Al-Dirbashi OY, 2005, CLIN CHEM, V51, P235
[2]   Diagnosis and management of glutaric aciduria type I [J].
Baric, I ;
Zschocke, J ;
Christensen, E ;
Duran, M ;
Goodman, SI ;
Leonard, JV ;
Müller, E ;
Morton, DH ;
Superti-Furga, A ;
Hoffmann, GF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (04) :326-340
[3]   Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I [J].
Baric, I ;
Wagner, L ;
Feyh, P ;
Liesert, M ;
Buckel, W ;
Hoffmann, GF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (08) :867-881
[4]   Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1 [J].
Bjugstad, KB ;
Goodman, SI ;
Freed, CR .
JOURNAL OF PEDIATRICS, 2000, 137 (05) :681-686
[5]  
CHALMERS RA, 1982, ORGANIC ACIDS MAN AN, P338
[6]   Indirect ultraviolet detection of biologically relevant organic acids by capillary electrophoresis [J].
Chen, H ;
Xu, Y ;
VanLente, F ;
Ip, MPC .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 679 (1-2) :49-59
[7]   GLUTARIC ACIDURIA - NEW DISORDER OF AMINO-ACID METABOLISM [J].
GOODMAN, SI ;
MARKEY, SP ;
MOE, PG ;
MILES, BS ;
TENG, CC .
BIOCHEMICAL MEDICINE, 1975, 12 (01) :12-21
[8]  
GOODMAN SI, 1995, METABOLIC MOL BASES, P1451
[9]   A GC/MS/MS screening method for multiple organic acidemias from urine specimens [J].
Hagen, T ;
Korson, MS ;
Sakamoto, M ;
Evans, JE .
CLINICA CHIMICA ACTA, 1999, 283 (1-2) :77-88
[10]   Glutaric aciduria type I: From clinical, biochemical and molecular diversity to successful therapy [J].
Hoffmann, GF ;
Zschocke, J .
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (04) :381-391